The proposal made by a Supreme Court Bench to have guidelines for legal reporting is seen as a serious threat to the freedom of the media. Paradoxes are not new to India. But the current challenges to the freedom of expression and the freedom of the media are sure to confound a future historian looking for explanations. The country is fortunate to have the best of historical circumstances that are conducive...
More »SEARCH RESULT
Total Matching Records found : 1132
Moratorium on Bt Brinjal-D Bandyopadhyay
On February 9, 2010, the then Minister of Environment and Forests, Government of India, Jairam Ramesh, imposed an indefinite moratorium on the introduction of Bt Brinjal in India. It is necessary and desirable to quote the order verbatim. It reads as follows: It is my duty to adopt a cautious, precautionary based approach and impose a moratorium on the release of Bt Brinjals till such time independent scientific studies establish, to...
More »Why was less food grain lifted for PDS, asks Bombay HC
-DNA Explain why more than 8.65 lakh metric tonnes (mt) of food grains meant for the poor under the Public Distribution System (PDS) have not been lifted between April and November 2011, the Bombay high court asked the state government on Thursday. A division bench of justice DD Sinha and justice V K Tahilramani, while directing the state government to file a detailed affidavit, said: “In areas such as Vidarbha, there is...
More »Delhi HC sniffs scam in farm ministry, orders FIR-Zia Haq
A Delhi court has ordered a first information report (FIR) and criminal investigations into allegations that the agriculture ministry had allegedly paid trumped-up bills worth nearly Rs. 14 lakh as legal fees to its standing counsel. The court said there was evidence to suggest a nexus between the counsel and ministry officials to cause loss to “public exchequer” through “fraud” and “misappropriation of funds”. The complaint, moved by the All India Federation...
More »Bayer to challenge Cipla’s decision to cut price of cancer drug
-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...
More »
